<DOC>
	<DOCNO>NCT00004733</DOCNO>
	<brief_summary>The ELLDOPA study control clinical trial patient newly diagnose PD determine optimal time dose levodopa ( Sinemet generic equivalent ) .</brief_summary>
	<brief_title>Timing Levodopa Treatment Parkinson 's Disease</brief_title>
	<detailed_description>The time begin levodopa therapy controversial many year , yet every patient PD , along his/her treat doctor , need make decision . One school think levodopa may lead develop motor fluctuation involuntary movement , therefore introduction delay . The oppose school think argues worsen severity disease time make patient susceptible problem , argue best response levodopa early stage illness improve quality life optimize levodopa . Another debated issue whether levodopa offer protection harmful remain dopamine neuron . The late study tissue culture show glia ( brain 's supportive cell ) tissue present addition nerve cell , glia tissue becomes protective levodopa toxicity . Because glia tissue present brain , argument make levodopa toxic living brain tissue . A study carry animal model PD . Two animal study suggest levodopa toxic neuron , two show levodopa toxic may actually protective effect . So convincing consistent evidence levodopa damage dopamine neuron human animal model PD . With uncertainty levodopa may remain dopamine cell patient PD , strong need make determination patient whether levodopa protects worsen progression PD . Primary End Point : Progression PD determine change PD rating scale , UPDRS , baseline examination examination Week 42 . These two examination conduct Primary Rater see subject twice : baseline Week 42 , influence effect subject may experience 40 week exposure investigational medication .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Early , mild PD , require medication Age 30 old Duration time diagnosis PD : less 2 year Hoehn &amp; Yahr Stage 1 2 Exposure levodopa dopamine agonist 14 day less</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2004</verification_date>
	<keyword>Parkinson 's</keyword>
	<keyword>ELLDOPA</keyword>
	<keyword>L-dopa</keyword>
	<keyword>levodopa</keyword>
	<keyword>Sinemet</keyword>
	<keyword>tremor</keyword>
</DOC>